1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Multiple Sclerosis Institute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis Avonex and Topamax - Multiple Sclerosis | Phase 2 | Unknown | Multiple Sclerosis Institute | 30 | 2004-04-01 | 2005-09-22 |
Disease Progression (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Interferon beta-1a (1) · Topiramate (1)
United States (1)